Williams-Sterling, Inc. (WSI) has entered a Reseller agreement with the Access Bio, Inc. the manufacturer of the
CareStart COVID-19 Antigen Home Test.
The CareStart COVID-19 Antigen Home Tests sold on an OTC basis directly to Consumers
pursuant to FDA issued EUA (EUA 210314) for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens from individuals
with or without symptoms or other epidemiological reasons to suspect a COVID-19 infection.
These test kits are available from WSI on a retail basis to individual consumers, Enterprise Users, Governments,
Schools, and/or Medical Networks; but only to the extent that the Products serve as a component of testing programs that cannot
use Point of Care tests.
WSI has a 4 million COVID-19 test kits per week commitment from our
manufacture. In continued support of DLA Troop Support's Medical supply chain, WSI can offer what we know is the most comprehensive, and responsive, planning/operations
deployment assistance solutions, as the Agency ramps up to buy more test kits, to supplement medical response support to states,
tribal nations, territories and large metropolitan areas as needed to support the nation's ongoing COVID-19 efforts.